InvestmentAug 5, 2026, 05:34 PM
Twist Bioscience Raises $327.1M in Upsized Public Offering
AI Summary
Twist Bioscience Corporation announced the pricing and closing of an upsized public offering of its common stock. The company sold 3,125,000 shares at $96.00 per share, and underwriters fully exercised their option to purchase an additional 468,750 shares. The offering is expected to generate approximately $327.1 million in net proceeds, which will be used for research and development, manufacturing expansion, product offerings, and general corporate purposes.
Key Highlights
- Twist Bioscience sold 3,125,000 shares of common stock in the offering.
- Underwriters exercised their option to purchase an additional 468,750 shares.
- Total shares sold amounted to 3,593,750 at $96.00 per share.
- Net proceeds to the company are expected to be approximately $327.1 million.
- Gross proceeds from the initial offering were $300.0 million.
- Proceeds will fund R&D, manufacturing expansion, product offerings, and general corporate purposes.
- The offering is expected to close on or about August 6, 2026.
Price Impact
More from TWST